SUSAN GIARDINO: Open Payments
NPI 1568564037 · LOCKPORT, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,465 in 66 payments from 23 companies in 2025. Trend: 2023 $1,192 · 2024 $1,200 · 2025 $1,465
Food & beverage: $1,410Long term medical supply or device loan: $55
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $162 |
| Abbott Laboratories | 5 | $151 |
| Amgen Inc. | 10 | $138 |
| Amneal Pharmaceuticals LLC | 5 | $122 |
| Ascendis Pharma Endocrinology Inc | 4 | $104 |
| Novo Nordisk Inc | 5 | $103 |
| Sequel Med Tech, LLC | 3 | $86 |
| Tandem Diabetes Care, Inc. | 3 | $71 |
| Mannkind Corporation | 3 | $65 |
| IBSA Pharma Inc. | 3 | $55 |
Products named: UNITHROID, JARDIANCE, Yorvipath, FREESTYLE LIBRE 3, TWIIST, TEPEZZA, t:slim X2 Insulin Pump with Control-IQ, AFREZZA.
Industry payments across NY — which companies pay providers there.
